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among the most interesting ones are phenotype characteristics that determine responses
to drug treatments, response to infections, or predisposition to speciﬁc inherited diseases.
Mostoftheresearchinthisﬁeldhasbeenfocusedonthestudiesofmutationeffectsonthe
ﬁnal gene products, peptides, and their alterations. Considerably less attention was given
to the mutations that may affect regulatory mechanism(s) of gene expression, although
these may also affect the phenotype characteristics. In this study we make a pilot analysis
of mutations observed in the regulatory regions of 24,667 human RefSeq genes. Our study
reveals that out of eight studied mutation types, “insertions” are the only one that in a
statistically signiﬁcant manner alters predicted transcription factor binding sites (TFBSs).
We also ﬁnd that 25 families ofTFBSs have been altered by mutations in a statistically sig-
niﬁcant manner in the promoter regions we considered. Moreover, we ﬁnd that the related
transcription factors are, for example, prominent in processes related to intracellular signal-
ing; cell fate; morphogenesis of organs and epithelium; development of urogenital system,
epithelium, and tube; neuron fate commitment. Our study highlights the signiﬁcance of
studying mutations within the genes regulatory regions and opens way for further detailed








can be freely accessed from public repositories such as HapMap
(Belmont et al., 2005), dbSNP (Sayers et al., 2010), and the 1000
Genomes project (Altshuler et al., 2010). It is well known that
phenotypic speciﬁcities determine how individuals react to drugs
(Batistetal.,2011;CallahanandAbercrombie,2011),toinfections
(González-Hernándezetal.,2010),orhowpredisposedtheyareto
inherited diseases such as cystic ﬁbrosis (Gu et al., 2009; Antigny
etal.,2011),Huntington’sdisease(Roze,2011),galactosemia(Ben-
nett, 2010), et cetera. Most of the research in this ﬁeld has been
focusedonthestudiesofnon-synonymousmutationeffectsonthe
ﬁnal gene products, peptides, and their alterations (Kumar et al.,
2009). Several databases have been developed in order to facili-
tate the study of these genetic variations and their consequences.
Resources such as the Human Gene Mutation Database (HGMD;
Stenson et al., 2009) and the Online Mendelian Inheritance in
Man (OMIM) database (Amberger et al., 2009) collect mutations
occurring across the entire human genome,whereas other reposi-
toriessuchastheFLCN GeneDatabase(Limetal.,2010)arelocus
speciﬁc.
However, a considerably less attention has been given to
the mutations that may affect regulatory mechanism of gene
expression, although these may also affect phenotype character-
istics. Previous studies of the interactions of mutations and reg-
ulatory processes have associated mutations within the promoter
region of certain key genes,with an increased susceptibility to dif-
ferentdisorderssuchasPancreaticcancer(Hamacheretal.,2009),
type2Diabetes(Songetal.,2009),Myelodysplasticsyndrome(Ma
et al.,2010),and Idiopathic PulmonaryArterial Hypertension (Yu
etal.,2009).Polymorphismsintheintragenicorregulatoryregions
may inﬂuence transcription factor (TF) binding to DNA or may
affect gene splicing (Heckmann et al.,2010;Kasowski et al.,2010).
A number of resources has been compiled to provide more easy
insights into effects of mutations to transcription and gene regu-
lation,such as those related to protein coding genes (Conde et al.,
2006; Kim et al.,2008),or for miRNA (Bao et al.,2007; Hariharan
et al.,2009;Alexiou et al., 2010; Schmeier et al., 2011).
Hereweperformedalarge-scalepilotstudyofmutationswithin
theregulatoryregionsof 24,667humanRefSeq(Pruittetal.,2009)
genes. Our study reveals for the ﬁrst time that out of eight studied
mutation types, “insertions” is the only type that alters the pre-
dicted transcription factor binding sites (TFBSs) in a statistically
signiﬁcant manner. We also identiﬁed 25 families of TFBSs have
been altered by mutations in a statistically signiﬁcant manner in
the promoter regions we considered. The related TFs are promi-
nentinprocessesrelatedtointracellularsignaling,cellfate,epithe-
lium, morphogenesis of organs and epithelium, development of
urogenitalsystem,epitheliumandtube,neuronfatecommitment,
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etcetera.Theseobservationshighlightthesigniﬁcanceof studying
mutationswiththegenesregulatoryregionsandopenswayforfur-
ther detailed studies on this topic,particularly on the downstream
affected pathways.
RESULTS
We analyzed promoter regions of 24,667 human genes from Ref-
Seqforthepresenceof TFBSsusingTransfacProfessionalver.11.4
(Matys et al., 2006) and we predicted 1,077,742 TFBSs in these
promoter regions. At the same time we found 343,024 mutations
associated with the same promoter regions based on data from
dbSNP. Of these, 122,023 TFBSs were altered by 104,514 muta-
tions.DetailsofthemappedmutationsandTFBSsbychromosome
are provided in Tables S1 and S2 in Supplementary Material,
respectively.
We analyzed the following eight mutations: “Single,” “Inser-
tion,” “Deletion,” “In-del,” “Multiple Nucleotide Polymorphism”
(MNP), “Mixed,” “Named,” and “Microsatellite.” “Single” repre-
sentssinglenucleotidevariation;withallobservedallelesaresingle
nucleotides (can have 2, 3, or 4 alleles). “Microsatellite” corre-
sponds to the situation when the observed allele from dbSNP is
a variation in counts of short tandem repeats.“Named”represent
polymorphismsinpresenceofcomplexstructures,astransposons,
e.g., (Alu)/-. “Mixed” corresponds to the cluster containing sub-
missions from multiple classes. MNP represent situation where
the alleles are all of the same length, and length >1. “Insertion”
corresponds an insertion relative to the reference assembly.“Dele-
tion” corresponds to a deletion relative to the reference assem-
bly. “In-del” corresponds to situation when both insertions and
deletions relative to reference genome were found in particu-
lar position. Our analysis suggests that only the insertion type
of mutations alters TFBSs in a statistically signiﬁcant manner
(Table 1). On the other hand, the analysis of TFBSs altered by
mutations indicates that 25 TFBS types are altered in a statisti-
callysigniﬁcantmanner.WeassociatedTFstothese25TFBStypes
and found that they comprise: HNF3 alpha, Pax-2, Pax-3, Pax-4,
Pax-5, Pax-6, AIRE, PLZF, myogenin/NF-1, ZNF219, FOX fac-
tors,STAT1,CHX10,HNF3beta,c-Maf,Tax/CREB,FOXP1,MyoD,
“c-Ets-1 p54,” KROX, DEAF1, VDR, CAR, PXR, FAC1, PPARal-
pha:RXRalpha, PPARgamma:RXRalpha, and Spz1. We also found
the initiator element,“Muscle initiator sequences-19,”is altered in
a statistically signiﬁcant manner (Table 2). Details including TFs
UniProt IDs (Jain et al., 2009)a r ep r o v i d e di nT a b l eS 3i nS u p -
plementary Material. We used GeneMANIA (Warde-Farley et al.,
2010) to analyze processes where the TFs which bind to the above
mentioned 25 TFBS types potentially exert their effects and found
(Table S4 in Supplementary Material) that in addition to activities
usually associated with TF functioning, they are also prominent
in processes related to intracellular signaling,cell fate,epithelium,
morphogenesis of organs and epithelium, development of uro-
genital system, epithelium and tube, neuron fate commitment,
response to nutrient levels, developmental processes, response to
extracellular stimulus.
DISCUSSION
The global analysis of mutations within TFBSs makes space for




a. the ability of altered TFBS to bind the same TFs remains
(though possibly with different afﬁnity)
b. altered TFBS cannot bind the original TFs
c. altered TFBS can bind new TFs as well as the original TFs
d. altered TFBS can only bind new TFs
e. altered TFBS cannot bind any TF
f. segmentof aregulatoryregionthatpreviouslydidnotbindany
TF, may acquire ability to bind some TFs, thus effectively new
TFBSs are introduced.
Studying such different scenarios in particular cases may pro-
vide insights into mutation effects (see Heckmann et al., 2010).
Schmeier et al. (2011) have developed a database that provides
a possibility to explore such potential effects of interactions of
mutations with TFBSs in the promoter regions of miRNAs.
Due to degenerative sequence properties of TFBS, one can
assume that many SNPs that overlap TFBSs will not affect the




long polymorphisms within TFBSs and for this reason, such long
polymorphisms are not likely to be signiﬁcantly enriched within
TFBSs.Thisiswhyourﬁndingthat“insertions”arestatisticallysig-
niﬁcantisaninterestingone.Furtherresearchisneededtosuggest
the reason behind such an observation.
We observed that TFBSs of two TF families, PAX and FOX,
are prominently associated with mutations. TFs from PAX family
are associated with tissue speciﬁc gene expression and linked to
development of speciﬁc tissues,including kidney and optic nerves
(PAX-2; Lindoso et al., 2009); ear, eye, and facial development
(PAX-3; Zhang et al., 2012); pancreatic islet beta cells (PAX-4;
Collombat et al., 2009); b-cell differentiation, as well as neural
and spermatogenesis development (PAX-5; Decker et al., 2009)
and eyes and sensory organs, certain neural, and epidermal tis-
sues development (PAX-6; Guo et al., 2010; Rowan et al., 2010).
Forkhead box (FOX) family of TFs is implicated in processes
of embryonic development, cell growth, proliferation, and cell
differentiation (Hannenhalli and Kaestner, 2009).
While insertion type of mutations was the only one that
appeared statistically signiﬁcantly altering TFBSs, the other seven
typescouldbeconsideredtoberesultsofuniformrandomchanges
of the genome.
The results obtained provide the foundation to investigate
potentially affected pathways that are controlled by the TFs bind-
ing the most affected TFBSs and provide us links to important
biological processes related to these TFs.
CONCLUSION
Our analysis revealed that “insertion” is only statistically signiﬁ-
cant type of mutations in the predicted TFBSs in the regulatory
regions of human genes that we explored. Also, we singled out 25
TFBS families that in our analysis appear statistically signiﬁcantly
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Table 1 | Enrichment of mutation types found altering predictedTFBSs.
Mutation type Total number of
mutations alteringTFBSs




Insertion 9374 20716 3.56E−003 2.85E−002
Single 86040 195689 2.57E−002 2.05E−001
Mixed 442 918 5.53E−002 4.42E−001
Named 218 482 3.63E−001 2.90E+000
MNP 168 370 3.67E−001 2.93E+000
In-del 2014 4616 5.69E−001 4.56E+000
Microsatellite 9 53 9.99E−001 7 .99E+000
Deletion 6249 15666 1.00E+000 8.00E+000
Table 2 | Statistically enriched alteredTFBSs.








PLZF 2721 10848 0.00E+000 0.00E+000
Pax-6 4671 27237 0.00E+000 0.00E+000
PPARgamma:RXRalpha, PPARgamma 5079 27438 0.00E+000 0.00E+000
AIRE 537 2172 0.00E+000 0.00E+000
myogenin/NF-1 6469 26368 0.00E+000 0.00E+000
STAT1 621 3639 0.00E+000 0.00E+000
FAC1 1583 10354 0.00E+000 0.00E+000
Pax-4 3942 8182 0.00E+000 0.00E+000
Pax-2 1431 9394 0.00E+000 0.00E+000
Pax-3 1942 9761 0.00E+000 0.00E+000
ZNF219 146 394 0.00E+000 0.00E+000
FOX factors 475 2348 0.00E+000 0.00E+000
Muscle initiator sequences-19 917 5364 3.74E−010 6.54E−008
DEAF1 205 972 3.94E−010 6.89E−008
PPARalpha:RXRalpha 2622 15957 6.72E−010 1.18E−007
VDR, CAR, PXR 1317 7229 7 .40E−010 1.29E−007
Spz1 2911 15960 7 .67E−010 1.34E−007
VDR 2841 17551 9.56E−010 1.67E−007
Pax-5 10529 43269 5.65E−009 9.88E−007
HNF3alpha 598 3701 1.06E−007 1.86E−005
Tax/CREB 2044 14374 3.04E−006 5.33E−004
c-Ets-1 p54 2749 19716 7 .93E−006 1.39E−003
Lhx3 64 265 1.20E−005 2.09E−003
Arnt 358 2205 2.25E−005 3.94E−003
FOXP1 16 34 8.03E−005 1.41E−002
altered by mutations. These open possibility to further explore
individual effects of the altered TFBSs and their downstream and
upstream regulation networks that can pave way for insights into




We extracted promoters regions of 24,667 human genes from Ref-
Seq (Pruitt et al., 2009). Promoters covered the region of [−1000,
+500]relativeto5 endofgene.Humangenomeversionhg19from
UCSC Genome Browser database (Fujita et al.,2011) is used.
Mutations
We downloaded 3,3026,121 SNPs from the UCSC Genome
Browser database (Fujita et al., 2011). These SNPs are derived
from dbSNP build 132 (Sayers et al., 2010) and are available on
the hg19 assembly of the human genome. The resulting set con-
tains 319,820 polymorphisms. Based on genomic coordinates we
identiﬁed SNPs that overlap promoter sequences, as well as those
altering predicted binding sites, using custom Perl scripts.
Binding sites of transcription factors
We used Transfac Professional database ver.11.4 (Matys et al.,
2006) and its associated Match program to map all binding sites
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Table 3 | Example of contingency table for mutation type
overrepresentation test.
Number of insertions altering any
TFBS
Number of all mutations, excluding
insertions, altering anyTFBS
Number of insertions not altering
TFBS
Number of all mutations, excluding
insertions, not altering anyTFBS
of vertebrate TFs to the promoter region. We used high quality
matrices and optimized threshold setting for“minimum FP.”This
allows for the TFBS predictions with presumed minimal number
of false positive predictions.
ENRICHMENT ANALYSIS
FortheTFsthatcorrespondtotheabovementioned25TFBStypes,
we used GeneMANIA (Warde-Farley et al.,2010) program to ﬁnd
out potentially enriched GO categories associated with these TFs.
STATISTICAL SIGNIFICANCE
To ﬁnd overrepresented types of mutations within all TFBSs, we
applied the right-sided exact Fisher’s test to contingency tables
(exampleisshowninTable 3)withBonferronicorrectionformul-
tiplicity testing. For each mutation types, we calculated the total
number of mutations of the considered type that overlapped any
TFBS or fell outside of any predicted TFBS. As a background we
used the total number of mutation of all other types that altered
Table 4 | Example of contingency table forTF HNF3 alpha
overrepresentation test.
Number of HNF3 alpha binding
sites altered by any mutations
Number of all, excluding HNF3 alpha bind-
ing sites, altered by any mutations
Number of HNF3 alpha binding
sites not altered by mutations
Number of all, excluding HNF3 alpha bind-
ing sites, not altered by mutations
The obtained p-values were corrected for multiplicity testing using Bonferroni
method.The signiﬁcance threshold of 0.05 was used. In the use of GeneMANIA
wereportthep-valuesgeneratedbythetoolanddeterminestatisticalsigniﬁcance
using 0.05 as the threshold value.
any TFBS or fell outside of any predicted TFBS. To ﬁnd TFBS
alteredsigniﬁcantlybyanyparticulartypeofmutationsweapplied
the exact Fisher’s test to contingency tables (example is shown in
the Table 4) with Bonferroni correction for multiplicity testing.
ForeachTF,wecalculatedthetotalnumberof differentmutations
altering any TFBS for a given TF or falling outside of such TFBS.
As a background we used the total number of TFBSs of all other
TF containing or not containing any mutations.
SUPPLEMENTARY MATERIAL
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